Indrayani Biotech

IBL Investments Trust (IN/AIF2/25-26/1900) is a SEBI-registered Category II Alternative Investment Fund (registered September 2025) managed by Indrayani Biotech Limited (IBL) — a publicly listed, Chennai-based MSME-focused conglomerate. IBL is listed on BSE/NSE and operates across food services, biotech/agri, power electronics, nutrition, healthcare, pharma, real estate, and investment management. IBL Investments is listed as one of IBL's group brands in the 'Investment' category. The SEBI-registered address is Block I, 3rd Floor, Module No. 32 and 33, Thiru Vi Ka Industrial Estate, SIDCO Electronic Complex, Guindy, Chennai – 600032. IBL's group brands include A-Diet Express (food courts/catering), Ennutrica (cow milk protein), Helios (power electronics), IBL Matrix (industrial boilers), Nalam (dental clinic), Nalla Sappadu (food court), Kniss Labs (pharma manufacturing), HSL Agri Solutions, HSL Prime (real estate), IBL Social Foundation (CSR), Vaasan (pharma retail), Dilasa Agro, Sepnil (disposable syringes), La Fuse Clinics (cosmetology), and IBL Investments.

Indrayani Biotech's strategic mission is to identify and aggregate MSMEs with high potential and expertise, facilitating vertical growth, unlocking value, while complementing existing promoters who shall continue to manage at the helm of affairs. The broader vision: to be the most trusted organisation for all stakeholders, achieving excellence, being socially responsible, and unlocking value resulting in inclusive growth.